newsfilter
← Latest News
Business Wire·

CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors

Mr. Claiborne Joined the CytRx Board of Directors as of the Annual Meeting CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, welcomes Mr. C